top of page

15.09.2020 Share Market Update | Stock Analysis, Results, Dividends and Important Data | MMM | TAMIL

Dear Millionaires, Market Update is a new playlist in our MMM channel introduced to cover the important data like previous day chart, results, top stocks, dividend and break out stocks for trading with ease.

News Corner

MARKET the Sensex ended 98 points lower to 38,756.63 while the Nifty50 ended at 11,440.05, down 24 points.

Gold rate today: Yellow metal trades higher; likely to face resistance at Rs 51,900 per 10 grams

Ashoka Buildcon | CMP: Rs 70.40 | The stock added 2 percent after the company bagged two EPC projects worth Rs 1,390 crore under Bharatmala-I.

Sun Pharma's shares declined 1.14 percent to Rs 499.80 per share on the NSE, at 12:20 pm after the company received a patent infringement action in the U.S. District Court of New Jersey from Orexo

Tata Motors | CMP: Rs 147.40 | The stock gained over 2 percent after a further improvement in Jaguar Land Rover sales for July and August over Q1FY21.

Infosys shares rise 4% on acquisition of GuideVision

AurionPro Solutions share price hits 5% upper circuit on order from Singapore bank

HCL Technologies shares jump 7% to hit 52-week high on strong Q2 update

TCS hits fresh 52-week high, market capitalisation crosses Rs.9 lakh crore

AstraZeneca Pharma shares surge 13% after parent company resumes vaccine trials in UK

India GDP: Rating agencies forecast contraction of 8 to 11.8% in FY21

Yes Bank | CMP: Rs 14.80 | The share price added a percent after ICICI Lombard announced it a tie-up with Yes Bank.

Adani Green Energy shares locked in 5% upper circuit; firm's m-cap nears Rs 1 lakh crore Silver futures up 0.45% to Rs 68,238 per kg on dollar weakness

Skipper Q1: Net loss at Rs 11.6 crore against profit of Rs 7.9 crore YoY. Revenue went down 34.8 percent at Rs 220.7 crore against Rs 338.5 crore

Natural gas rises nearly 3% to Rs 173.20 per mmBtu on strong overseas cues

Indoco Remedies | CMP: Rs 247.35 | The share price surged 12 percent after the company received approval from the US health regulator for blood-thinning drug apixaban.

RITES | CMP: Rs 251.60 | The stock gained over 3 percent after the company said that a meeting of the Board of Directors will be held on September 18 to consider the proposal for a buy-back of the fully paid-up equity shares of the company.

8 views0 comments


bottom of page